
- Volume 0 0
Diabetes Treatment Improves with Exubera
A treatment including inhaled insulin(Exubera) improves blood sugar levelsbetter than treatment consisting of diabetespills alone. Researchers conductedan open-label, 12-week, multicenter, randomizedstudy of 309 patients with type2 diabetes, aged 35 to 80, who were taking2 diabetes pills. The patients wererandomly switched to inhaled insulinalone, asked to add inhaled insulin totheir regimen of 2 pills, or remained ontheir regimen of 2 diabetes pills alone.With the recommended treatment bloodsugar goal at 7, these patients enteredthe study with blood sugar levels of 9.5to 9.6. Patients taking just the inhaledinsulin improved their blood sugar levelsby 1.4; patients taking just the 2 diabetespills improved their blood sugar levels by0.2; and patients taking the diabetes pillsplus the inhaled insulin improved theirblood sugar levels by 1.9. There were noincidences of treatment-related discontinuationsby any of the study's participants.The most common side effectswith inhaled insulin were hypoglycemiaand mild cough. According to lead investigatorJulio Rosenstock, MD, of theDallas Diabetes and Endocrine Center,"Exubera resulted in significant improvementsin blood sugar control, withmarked reductions in blood sugar levels,which is the ultimate objective for anypatient with diabetes."
Ms. Farley is a freelance medicalwriter based in Wakefield, RI.
Articles in this issue
almost 20 years ago
Resealable and Nultraviolet Ultraviolet (UV) Inhibitant Bagsalmost 20 years ago
High Alert Insulin Binalmost 20 years ago
Hydase (hyaluronidase injection, USP)almost 20 years ago
Humira (adalimumab)almost 20 years ago
INVANZ (ertapenem for injection)almost 20 years ago
Compounding HOTLINEalmost 20 years ago
Customer Guilty of Prescription Fraud by Supporting Friendalmost 20 years ago
Counterfeit Drugs: A Life-or-Death Problemalmost 20 years ago
Qui Tam Lawsuits Blow the Whistle on PBMsalmost 20 years ago
Can You Read These Rxs?Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.